Vince Martin

Vince Martin

InvestorPlace Contributor

Vince Martin has written investing advice for several years, covering stocks across a range of industries. A former registered representative, Martin saw the dot-com bubble inflate and burst in real time, creating a healthy respect for downside risk. He splits his time between Chicago and rural Wisconsin with his wife and three dogs.

Recent Articles

Ocugen Stock Is Not for the Faint of Heart

By Vince Martin, InvestorPlace Contributor

Ocugen stock has an intriguing bull case based on its pipeline. But the nano-cap biotech is as risky as any stock in the space.

3 Stocks That Will Hit All-Time Lows in 2020

By Vince Martin, InvestorPlace Contributor

These stocks are headed to new lows in 2020 even if U.S. stocks keep making new all-time highs.

3 Big Stock Charts for Wednesday: Biogen, Cooper Companies, and Maxim

By Vince Martin, InvestorPlace Contributor

Wednesday's big stock charts highlight 3 stocks looking to break through resistance in a market that looks a bit shaky at the moment.

Same Old Story When It Comes to Marathon Oil

By Vince Martin, InvestorPlace Contributor

Marathon Oil stock has predictably faded amid lower long-term oil prices. But for energy bulls, the core investment case for MRO stock still holds.

The Rally in Microsoft Stock Will Slow — But Should Continue

By Vince Martin, InvestorPlace Contributor

MSFT stock has added a staggering $460 billion in market capitalization in the last year, and it will add more in the next 12 months

3 Big Stock Charts for Tuesday: Pfizer, Clorox, and L Brands

By Vince Martin, InvestorPlace Contributor

Tuesday's big stock charts focus on 3 value plays that are looking to continue recent breakouts.

3 Big Stock Charts for Monday: UnitedHealth Group, CSX, and Occidental Petroleum

By Vince Martin, InvestorPlace Contributor

These 3 big charts show stocks that have bounced off the bottom — but may struggle to keep recent rallies going.

7 Earnings Reports to Watch Next Week

By Vince Martin, InvestorPlace Contributor

These seven earnings reports next week are worth highlighting. Here's what you might expect when each of these companies makes their report.

Aurora Cannabis Stock May Already Have a U.S. Problem

By Vince Martin, InvestorPlace Contributor

Like many cannabis plays, the long-term case for ACB stock includes the U.S. market. But Aurora Cannabis may not be able to capitalize.

3 Big Stock Charts for Friday: Square, American Airlines, and Kinder Morgan

By Vince Martin, InvestorPlace Contributor

Friday's 3 big stock charts focus on three names looking to make a big move, and looking for broad market help in the process.

Load More